These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23985808)

  • 1. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism.
    Musso G; Bo S; Cassader M; De Michieli F; Gambino R
    Am J Clin Nutr; 2013 Oct; 98(4):895-906. PubMed ID: 23985808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism.
    Musso G; Cassader M; Bo S; De Michieli F; Gambino R
    Diabetes; 2013 Apr; 62(4):1109-20. PubMed ID: 23274901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis.
    Musso G; Cassader M; De Michieli F; Saba F; Bo S; Gambino R
    Am J Clin Nutr; 2011 Oct; 94(4):1033-42. PubMed ID: 21865331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.
    Musso G; Gambino R; Pacini G; Pagano G; Durazzo M; Cassader M
    Hepatology; 2009 Feb; 49(2):426-35. PubMed ID: 19105201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
    Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
    Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
    Musso G; Cassader M; De Michieli F; Paschetta E; Pinach S; Saba F; Bongiovanni D; Framarin L; Berrutti M; Leone N; Corvisieri S; Parente R; Molinaro F; Sircana A; Bo S; Gambino R
    Hum Mol Genet; 2017 May; 26(9):1747-1758. PubMed ID: 28334911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
    Musso G; Saba F; Cassader M; Paschetta E; De Michieli F; Pinach S; Framarin L; Berrutti M; Leone N; Parente R; Ayoubi Khajekini MT; Zarovska A; Gambino R
    Am J Gastroenterol; 2019 Apr; 114(4):607-619. PubMed ID: 30920415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
    Musso G; Gambino R; Pacini G; De Michieli F; Cassader M
    Am J Clin Nutr; 2009 Feb; 89(2):558-67. PubMed ID: 19141695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between SREBF-1c gene polymorphisms and risk of non-alcoholic fatty liver disease in a Chinese Han population.
    Peng XE; Chen FL; Liu W; Hu Z; Lin X
    Sci Rep; 2016 Aug; 6():32110. PubMed ID: 27572914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.
    Musso G; Cipolla U; Cassader M; Pinach S; Saba F; De Michieli F; Paschetta E; Bongiovanni D; Framarin L; Leone N; Berrutti M; Rosina F; Corvisieri S; Molinaro F; Sircana A; Gambino R
    J Lipid Res; 2017 Jun; 58(6):1221-1229. PubMed ID: 28242789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.
    Musso G; Gambino R; Cassader M
    J Nutr Biochem; 2010 Sep; 21(9):834-40. PubMed ID: 19733470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.
    Musso G; Gambino R; De Michieli F; Durazzo M; Pagano G; Cassader M
    Hepatology; 2008 Apr; 47(4):1167-77. PubMed ID: 18311774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
    Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
    Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?
    Gambino R; Cassader M; Pagano G; Durazzo M; Musso G
    Hepatology; 2007 May; 45(5):1097-107. PubMed ID: 17464986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.
    Musso G; Gambino R; De Michieli F; Biroli G; Premoli A; Pagano G; Bo S; Durazzo M; Cassader M
    Am J Clin Nutr; 2007 Sep; 86(3):661-71. PubMed ID: 17823431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A
    Adv Exp Med Biol; 2024; 1460():539-574. PubMed ID: 39287864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.
    Knebel B; Haas J; Hartwig S; Jacob S; Köllmer C; Nitzgen U; Muller-Wieland D; Kotzka J
    PLoS One; 2012; 7(2):e31812. PubMed ID: 22363740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
    Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M
    J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.